In many cases, we’ve simply layered new tools onto an outdated operating model. The structure beneath—the way clinical trials ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

With artificial intelligence (AI) fast becoming an ubiquitous part of everyday life, its further application in clinical ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Racial and ethnic diversity is lacking in PsA clinical trials, with non-White participants remaining severely underrepresented.

The funder of the study had no role in study design, data collection, data analysis ... UK), Dr Jerome Wulff (Cambridge Clinical Trials Unit - Cancer Theme, Cambridge, UK) and Professor Dileep Lobo ...

Our work focuses on benchmarking multiple SQL-like big data technologies over Hadoop based distributed file system (HDFS) for Study Data Tabulation Model (SDTM) used in clinical trial databases for ...

Logistics and sample handling are critical components of central lab services, and issues with these processes can limit the growth of the central lab market. PORTLAND, OR, UNITED STATES, July 4, 2025 ...

IRB approval from TASMC follows Clearmind’s prior regulatory milestones, including U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug (IND) application and IRB approvals ...